YONGAN PHARMACEUTICAL: Controlling shareholder reduces holdings by 410,000 shares

YONGAN PHARMACEUTICAL announced that its controlling shareholder's concerted actor, Huanggang Yongan, reduced its holdings by 410,000 shares through centralized bidding on September 4, 2025, accounting for 0.1391% of the total share capital. After this equity change, the company's controlling shareholders, actual controllers, and their concerted actors collectively hold 73,587,200 shares, accounting for 24.9717%, reaching a multiple of 5%